Trials / Conditions / Alveolar Soft Part Sarcoma

Alveolar Soft Part Sarcoma

17 registered clinical trials studyying Alveolar Soft Part Sarcoma — 7 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours NCT07297667	Canadian Cancer Trials Group	Phase 1
Recruiting	Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors NCT06625190	University of Florida	Phase 1 / Phase 2
Not Yet Recruiting	Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk T NCT06526897	ECOG-ACRIN Cancer Research Group	N/A
Active Not Recruiting	GPNMB-targeting Chimeric Antigen Receptor T-Cell Therapy (GCAR1) for a Patient With Alveolar Soft Part Sarcoma NCT06789081	AHS Cancer Control Alberta	EARLY_Phase 1
Completed	GPNMB-targeting Chimeric Antigen Receptor T-Cell Therapy (GCAR1) for a Patient With Alveolar Soft Part Sarcoma NCT06827886	AHS Cancer Control Alberta	EARLY_Phase 1
Recruiting	AB122 Platform Study NCT04999761	Taiho Pharmaceutical Co., Ltd.	Phase 1
Recruiting	Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Proje NCT03967834	Institut Claudius Regaud	N/A
Withdrawn	Selinexor in Combination With Ixazomib for the Treatment of Advanced Sarcoma NCT03880123	Matthew Ingham	Phase 1
Recruiting	A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma NCT04332874	Memorial Sloan Kettering Cancer Center	Phase 2
Unknown	Clinical Trial in Chinese Patients of Elapsed/Metastatic/Unresectable Alveolar Soft Part Sarcoma(GB226) NCT03623581	Genor Biopharma Co., Ltd.	Phase 2
Unknown	Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas NCT03989596	Maria Sklodowska-Curie National Research Institute of Oncology	Phase 2
Recruiting	Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial S NCT03016819	Advenchen Laboratories, LLC	Phase 3
Active Not Recruiting	Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wi NCT02867592	National Cancer Institute (NCI)	Phase 2
Completed	Axitinib and Pembrolizumab in Subjects With Advanced Alveolar Soft Part Sarcoma and Other Soft Tissue Sarcomas NCT02636725	Jonathan Trent, MD, PhD	Phase 2
Active Not Recruiting	Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients Wi NCT02180867	National Cancer Institute (NCI)	Phase 2 / Phase 3
Unknown	A Trial of Cediranib in the Treatment of Patients With Alveolar Soft Part Sarcoma (CASPS) NCT01337401	Institute of Cancer Research, United Kingdom	Phase 2
Completed	Collection of Alveolar Soft Part Sarcoma and Blood Specimens for Research NCT00340353	National Cancer Institute (NCI)	—